BWCS
Beirne Wealth Consulting Services’s Altimmune ALT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Buy |
342,458
+48,000
| +16% | +$186K | 0.43% | 39 |
|
|
2025
Q1 | $1.47M | Hold |
294,458
| – | – | 0.52% | 34 |
|
|
2024
Q4 | $2.12M | Sell |
294,458
-8,342
| -3% | -$60.1K | 0.77% | 29 |
|
|
2024
Q3 | $1.86M | Buy |
302,800
+25,000
| +9% | +$154K | 0.65% | 29 |
|
|
2024
Q2 | $1.85M | Buy |
277,800
+5,000
| +2% | +$33.3K | 0.74% | 29 |
|
|
2024
Q1 | $2.78M | Sell |
272,800
-31,000
| -10% | -$316K | 1.18% | 23 |
|
|
2023
Q4 | $3.42M | Buy |
303,800
+54,380
| +22% | +$612K | 1.69% | 13 |
|
|
2023
Q3 | $880K | Hold |
249,420
| – | – | 0.7% | 33 |
|
|
2023
Q2 | $880K | Hold |
249,420
| – | – | 0.7% | 33 |
|
|
2023
Q1 | $1.05M | Buy |
249,420
+12,400
| +5% | +$52.3K | 0.74% | 27 |
|
|
2022
Q4 | $3.9M | Sell |
237,020
-45,800
| -16% | -$753K | 1.92% | 11 |
|
|
2022
Q3 | $3.61M | Sell |
282,820
-1,827
| -0.6% | -$23.3K | 1.37% | 13 |
|
|
2022
Q2 | $3.33M | Buy |
284,647
+100,807
| +55% | +$1.18M | 2.18% | 10 |
|
|
2022
Q1 | $1.12M | Buy |
183,840
+47,000
| +34% | +$286K | 0.62% | 37 |
|
|
2021
Q4 | $1.26M | Buy |
136,840
+4,900
| +4% | +$44.9K | 0.69% | 26 |
|
|
2021
Q3 | $1.49M | Sell |
131,940
-1,830
| -1% | -$20.7K | 0.85% | 25 |
|
|
2021
Q2 | $1.32M | Buy |
133,770
+21,000
| +19% | +$207K | 0.72% | 28 |
|
|
2021
Q1 | $1.59M | Buy |
112,770
+36,545
| +48% | +$516K | 0.94% | 24 |
|
|
2020
Q4 | $860K | Buy |
+76,225
| New | +$860K | 0.43% | 47 |
|